Medical Value & Outcomes Liaison

About Us

We are a global, family-owned company driven by a passion for innovation. Building on our foundational expertise in carbohydrate chemistry and cell cycle biology, we develop innovative treatments for unmet patient needs, with a focus on iron metabolism and blood-related disorders.

• People-Driven – We are a family-held company built on passionate, knowledgeable people. We value integrity, open-mindedness and respect and are guided by these values in all our endeavors. We respect each individual who becomes a part of our journey, from our employees and partners to our end-users. And we recognize that the strength in all our collaborations is trust.
• Committed to Quality – Quality is our source of inspiration. Quality drives our results. It represents our aspiration for excellence and our focus on driving continual improvements. For our partners and end-users, quality must always be tangible in our products, processes and people. This way, quality is the promise we keep every day.
• Innovating for Better Lives – Innovation is essential in our quest to improve the lives of humans. We seek to address unmet needs through our expertise in iron and carbohydrate-based pharmaceuticals. We believe in a holistic and collaborative approach to research and innovation, so we work together with the scientific and medical communities to set new standards.

We have continued our growth trajectory since we launched our first product in the US, Monoferric® (ferric derisomaltose), through acquisitions, partnerships, and pipeline. Our R&D investments continue to leverage our core competencies, alongside our recent advancements in oncology supportive care. Join us in shaping the future of patient care through innovation and collaboration.

The Medical Value and Outcomes Liaison (MVOL) is a field-based non-promotional US medical expert responsible for advancing scientific exchange and building strategic relationships with national population health decision makers (PHDMs) and within identified strategic accounts. This position will serve as a compliant medical partner supporting market access strategy through scientific exchange of the clinical and pharmacoeconomic value of PTI therapies/pipeline products to key PHDM stakeholders in community oncology, Integrated Delivery Networks (IDN), payor, Group Purchasing Organizations (GPO), and clinical pathway organizations.

The role of the MVOL is non-promotional in nature and serves as a trusted scientific partner to translate health economics and outcomes research (HEOR) and real-world evidence (RWE) to key PHDM stakeholders, while extracting actionable insights to support evidence-based healthcare decisions.

• Serve as a primary field medical lead to generate and execute scientific discussions building awareness and clinically differentiating PTI therapies within assigned strategic accounts, inclusive of national community oncology large practice networks, IDN’s, Integrated Payor Provider Networks (IPPNs), payors, and GPOs
• Develop key opinion leader (KOL) and PHDM relationships across all assigned strategic account segments
• Contribute meaningfully as a key medical stakeholder within a highly collaborative matrix environment, focusing on supporting market access and the medical HEOR team through scientific exchange in PHDM discussions reviewing the clinical and pharmacoeconomic totality of evidence for PTI therapies leveraging RWE, economic modeling, value dossiers, and budget impact models
• Identify and facilitate approval of HEOR/RWE data generation opportunities aligned with medical affairs gap analysis and publication plans
• Collect insights to identify treatment barriers, patient identification…